Neurology Today in 5

De: American Academy of Neurology
  • Sumário

  • Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
    2024
    Exibir mais Exibir menos
Episódios
  • Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
    Nov 21 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.

    Exibir mais Exibir menos
    5 minutos
  • Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
    Nov 7 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.

    Exibir mais Exibir menos
    4 minutos
  • Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
    Oct 17 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

    This Podcast is being Sponsored by LocumTenens.com

    Exibir mais Exibir menos
    5 minutos

O que os ouvintes dizem sobre Neurology Today in 5

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.